Harbour Biomed prices IPO above mid point

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

Harbour Biomed prices IPO above mid point

Jonathan Breen
December 07, 2020 08:15 AM
biopharma_stocks_adobe_575x375.jpg

Harbour Biomed has pocketed HK$1.71bn ($220.8m) by pricing its IPO just above the mid point of the marketed range.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC SecuritiesCredit SuisseEquity IPOsHealth and BiotechEquityChina Merchants Bank CoChinaChina International Capital CorpHong Kong SARAsiaGreater ChinaHaitong SecuritiesNortheast AsiaGuotai Junan Securities CoAsia PacificSRIBank of AmericaMorgan StanleyEmerging Markets
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article